They're all talking about HPV, or human papillomavirus. It's the most common sexually transmitted infection, but it's also ...

A potential new cancer vaccine could be on the horizon as a study has yielded “exciting” results. Scientists have revealed ...

That’s thanks to a major philanthropic commitment from Sarasota’s Brian and Sheila Jellison Family Foundation. As the first ...

Cancer researchers are one step closer to developing an effective vaccine to treat people with clear cell renal cell ...

Vaccines generated using the cells left over after tumour removal surgery could help to keep patients from redeveloping ...

A new vaccine for kidney cancer shows excellent preliminary results. All patients on the trial had no evidence of cancer ...

Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still ...

A groundbreaking study has delivered "exciting" findings, indicating that a new cancer vaccine could be on the verge of ...

In a Phase 1 study, nine people with advanced kidney cancer became cancer free after receiving personalized vaccines.

The cure rate for [diffuse midline glioma] is less than 1%, and the median overall survival is nine to 11 months,” said Dr.

A neoantigen-targeting personalized cancer vaccine may be effective as adjuvant therapy in patients with high-risk clear cell renal cell carcinoma, phase 1 data suggest.

The vaccine acts like a "wanted poster" unmasking cancer cells that are adept at hiding in the body, only to resurface later.